Loading view.
Featured Industry Symposium
The Expanding Role of Precision Medicine with Antibody Drug Conjugates in NSCLC
Hall 405C
Sponsored by AbbVie
Satellite CME Symposium
A Bold Frontier: Shattering the Limits of Conventional Therapies and Reshaping the Future of Lung Cancer Treatment with TROP2-Targeting ADCs and Rational Combinations
Hall 405A
Sponsored by PVI, PeerView Institute for Medical Education
Supported by an educational grant from Gilead
Industry Symposium
Hitting the Mark: Emerging Biomarkers in Advanced NSCLC
Hall 405C
Sponsored by Sanofi
Industry Symposium
Academy for Cancer Education (ACE) Asia Pacific Lung Cancer Symposium: Emerging Strategies in EGFR Driver Mutation-Based Management of Advanced Non-small Cell Lung Cancer (NSCLC)
Hall 405B
Sponsored by by Janssen
Industry Symposium
Past, Present, and Future of Personalized Care in Lung Cancer: HER2 and DLL3 Targeted Therapies in Focus
Hall 405A
Sponsored by Boehringer Ingelheim
Featured Satellite CME Symposium
Unlocking the Power of Genomic Testing in NSCLC: Implementing Personalized Therapy to Impact Outcomes
Hall 406
Sponsored by Medscape Oncology
Supported by an educational grant from Lilly
Industry Symposium
Maximising the Potential in ALK+ NSCLC: Enhancing Outcomes and Improving Patient Care
Hall 405C
Sponsored by Pfizer
Satellite CME Symposium
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
Hall 406
Sponsored by PeerVoice
Supported by an educational grant from Daiichi Sankyo, Inc.